Cargando…
Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986485/ https://www.ncbi.nlm.nih.gov/pubmed/35443916 http://dx.doi.org/10.1016/j.vaccine.2022.04.005 |
| _version_ | 1784682554910048256 |
|---|---|
| author | Linkins, Lori-Ann Iorio, Alfonso Little, Julian Lavis, John |
| author_facet | Linkins, Lori-Ann Iorio, Alfonso Little, Julian Lavis, John |
| author_sort | Linkins, Lori-Ann |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8986485 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89864852022-04-07 Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19 Linkins, Lori-Ann Iorio, Alfonso Little, Julian Lavis, John Vaccine Letter to the Editor Elsevier Ltd. 2022-05-11 2022-04-07 /pmc/articles/PMC8986485/ /pubmed/35443916 http://dx.doi.org/10.1016/j.vaccine.2022.04.005 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Linkins, Lori-Ann Iorio, Alfonso Little, Julian Lavis, John Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19 |
| title | Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19 |
| title_full | Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19 |
| title_fullStr | Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19 |
| title_full_unstemmed | Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19 |
| title_short | Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19 |
| title_sort | extended reporting guidance for vaccine effectiveness studies for variants of concern for covid-19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986485/ https://www.ncbi.nlm.nih.gov/pubmed/35443916 http://dx.doi.org/10.1016/j.vaccine.2022.04.005 |
| work_keys_str_mv | AT linkinsloriann extendedreportingguidanceforvaccineeffectivenessstudiesforvariantsofconcernforcovid19 AT iorioalfonso extendedreportingguidanceforvaccineeffectivenessstudiesforvariantsofconcernforcovid19 AT littlejulian extendedreportingguidanceforvaccineeffectivenessstudiesforvariantsofconcernforcovid19 AT lavisjohn extendedreportingguidanceforvaccineeffectivenessstudiesforvariantsofconcernforcovid19 |